The U.S. Food and Drug Administration (FDA) announced today, Aug 2, its intent to “quickly advance” three new initiatives concerning tobacco and vapor products.Read More

The Tobacco Products Scientific Advisory Committee (TPSAC), which advises the U.S. Food and Drug Administration (FDA), has denied the first effort by Philip Morris International (PMI) to label its iQOS device as a modified-risk Read More

The US FDA has moved the PMTA application deadline to Aug. 8 2022, giving the vapor industry 4 additional years to sell products that were on the market before Aug. 8 2016.Read More

Guidance has been issued concerning the deadlines for compliance with those US Food and Drug Administration’s deeming regulations that have been extended.Read More

The US Food and Drug Administration’s Center for Tobacco Products considers vapor a tobacco product. The regulatory agency is due to explain the processes it uses in the review of tobacco product applications.Read More

What started as just a general disagreement against FDA regulations, quickly became an amendment sponsored by Rep. Tom Cole and Rep. Sanford Bishop. Together, they have formed a movement to keep vaping products on the Read More

A court brief by the US Food and Drug Administration seems to indicate that synthetic nicotine does not of itself fall under the remit of the deeming regulations.Read More

Philip Morris International has filed its highly anticipated MRTP application with the FDA. The company is seeking the right to make a health claim on its iQOS heat-not-burn vaporizer.Read More

The rumors are unfounded. The FDA will publish a rule change today that will address how it "refuses to accept" premarket tobacco applications. A meaningless notion for most vapor companies.Read More